Datasetspublic full text
ClinicalTrials.gov
clinicaltrials · Datasets · License: Public Domain
186,442Documents
1,450Full text
2026-10-02Last indexed
Recent documents from this source
- Vildagliptin Compared to Gliclazide in Combination With Metformin in Patients With Type 2 Diabetes#126091
- Metformin in Combined With Cisplatin Plus Paclitaxel With Advanced Esophageal Squamous Cell Carcinoma (ECMTPneo)#126090
- Combined Use of Cyclosporine and Metformin in Treatment of Psoriasis vs Cyclosporine Alone#126089
- Phase 3 Alogliptin Pediatric Study#126088
- The Effect of a Multistrain Probiotic on Metformin Tolerance and Efficacy With Microbiota and Stool Metabolome in Insulin-resistant Women - a 12-week Randomized, Placebo-controlled, Double-blind Study#126087
- Comparison of NN1250 With Sitagliptin in Subjects With Type 2 Diabetes Never Treated With Insulin#126086
- A Relative Bioavailability Study of Metformin HCl 750 mg ER Tablets Under Fasting Conditions#126085
- A Study to Evaluate the Pharmacokinetics and Safety Between "BR3006" and Co-administration of "BR3006A", "BR3006B", and "BR3006C" in Healthy Adult Volunteers (Fasting)#126084
- Effect of Metformin Use on Mortality in Diabetic and Non Diabetic Patients With Sepsis and Septic Shock.#126083
- A Study to Assess the Effects of Savolitinib on the Pharmacokinetics of Digoxin, Rosuvastatin, Metformin, and Furosemide in Healthy Male Subjects#126082
- Efficacy and Safety of Dapagliflozin in Combination With Glimepiride (a Sulphonylurea) in Type 2 Diabetes Patients#126081
- Prevention of Progression of Prediabetes, Obesity and CV Risk#126080
- The Effect of Metformin Treatment on Thyroid Hormone Metabolism in Euthyroid Patients With Type 2 Diabetes Mellitus#126079
- Observational Study to Evaluate the Efficacy and Safety of Suganon Tab. or Sugamet XR Tab.#126078
- Comparison of Pioglitazone Versus Glimepiride in Type 2 Diabetes Inadequately Controlled With Metformin Plus Alogliptin#126077
- A Study Investigating Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GSK2330672 Administered With Metformin to Type 2 Diabetes Patients#126076
- BE Study of the Fixed Dose Combination of 5 mg Saxagliptin and 500 mg Metformin HCl XR Tablet Relative to a 5 mg Saxagliptin (Onglyza™) Tablet and a 500 mg Metformin HCl XR (Glifage® XR Marketed in Brazil by Merck S.A.) Tablet Co-Administered to Healthy Subjects in the Fasted and Fed States#126075
- Assessment of Safety and Efficacy of Therapy for the Prevention of Weight Gain Associated With Olanzapine#126074
- Aerobic Versus Resistance Exercises on Insulin Sensitivity in Obese Patients#126073
- Evaluate Efficacy and Safety of Saxagliptin in Combination With Metformin in Adult Patients With Type 2 Diabetes#126072
Source record · clinicaltrials · Datasets · License: Public Domain
Conceptio Open Knowledge Archive — counts are materialised per sync from the index (real full-text coverage, never license entitlement).